Published in Mol Cell Biol on April 01, 1987
Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol (1989) 6.69
Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol (1988) 4.64
Factors that bind to adeno-associated virus terminal repeats. J Virol (1989) 3.56
Parvovirus replication. Microbiol Rev (1990) 3.37
Cloning and characterization of adeno-associated virus type 5. J Virol (1999) 3.36
Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization. J Virol (1992) 2.84
Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein. J Virol (1989) 2.53
Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein. J Virol (1994) 2.52
Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins. EMBO J (1990) 2.35
Biologically active Rep proteins of adeno-associated virus type 2 produced as fusion proteins in Escherichia coli. J Virol (1994) 2.32
Sequence requirements for binding of Rep68 to the adeno-associated virus terminal repeats. J Virol (1996) 2.32
Role for highly regulated rep gene expression in adeno-associated virus vector production. J Virol (1997) 2.19
Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A (1996) 2.12
Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J Virol (1997) 2.06
The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. J Virol (1988) 2.00
The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification. J Virol (1990) 2.00
Sequence requirements for stable binding and function of Rep68 on the adeno-associated virus type 2 inverted terminal repeats. J Virol (1994) 1.98
Regulation of adeno-associated virus gene expression in 293 cells: control of mRNA abundance and translation. J Virol (1988) 1.80
A maltose-binding protein/adeno-associated virus Rep68 fusion protein has DNA-RNA helicase and ATPase activities. J Virol (1995) 1.72
Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters. J Virol (1995) 1.71
Replication of adeno-associated virus in cells irradiated with UV light at 254 nm. J Virol (1989) 1.67
Terminal regions of the NS-1 protein of the parvovirus minute virus of mice are involved in cytotoxicity and promoter trans inhibition. J Virol (1992) 1.64
Adeno-associated virus Rep protein inhibits human immunodeficiency virus type 1 production in human cells. J Virol (1991) 1.59
Mutation of a consensus purine nucleotide binding site in the adeno-associated virus rep gene generates a dominant negative phenotype for DNA replication. J Virol (1990) 1.56
Adeno-associated virus (AAV) type 5 Rep protein cleaves a unique terminal resolution site compared with other AAV serotypes. J Virol (1999) 1.55
Adeno-associated virus rep protein synthesis during productive infection. J Virol (1989) 1.54
Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levels. J Virol (1994) 1.48
Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins. J Virol (1994) 1.46
Mutation of lysine 405 to serine in the parvovirus H-1 NS1 abolishes its functions for viral DNA replication, late promoter trans activation, and cytotoxicity. J Virol (1990) 1.45
In vivo resolution of circular plasmids containing concatemer junction fragments from minute virus of mice DNA and their subsequent replication as linear molecules. J Virol (1992) 1.45
The adeno-associated virus rep gene inhibits replication of an adeno-associated virus/simian virus 40 hybrid genome in cos-7 cells. J Virol (1988) 1.42
Generation and characterization of a temperature-sensitive mutation in the NS-1 gene of the autonomous parvovirus minute virus of mice. J Virol (1988) 1.36
Mutational analysis of the adeno-associated virus rep gene. J Virol (1992) 1.35
A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity. J Virol (1994) 1.30
Encapsidation of adeno-associated virus type 2 Rep proteins in wild-type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells. J Virol (1997) 1.23
Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products. J Virol (1997) 1.21
Cloning of minute virus of mice cDNAs and preliminary analysis of individual viral proteins expressed in murine cells. J Virol (1990) 1.20
Inhibition of PrKX, a novel protein kinase, and the cyclic AMP-dependent protein kinase PKA by the regulatory proteins of adeno-associated virus type 2. Mol Cell Biol (1998) 1.20
Both excision and replication of cloned autonomous parvovirus DNA require the NS1 (rep) protein. J Virol (1989) 1.19
Susceptibility of human cells to killing by the parvoviruses H-1 and minute virus of mice correlates with viral transcription. J Virol (1990) 1.17
The adeno-associated virus type 2 regulatory proteins rep78 and rep68 interact with the transcriptional coactivator PC4. J Virol (1999) 1.14
Identification of cellular proteins that interact with the adeno-associated virus rep protein. J Virol (2008) 1.12
Inhibition of S-phase progression by adeno-associated virus Rep78 protein is mediated by hypophosphorylated pRb. EMBO J (2000) 1.10
Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins. J Virol (1997) 1.10
Charged-to-alanine scanning mutagenesis of the N-terminal half of adeno-associated virus type 2 Rep78 protein. J Virol (1999) 1.10
Amino-terminal domain exchange redirects origin-specific interactions of adeno-associated virus rep78 in vitro. J Virol (2001) 1.09
Adeno-associated virus Rep78 protein interacts with protein kinase A and its homolog PRKX and inhibits CREB-dependent transcriptional activation. J Virol (1998) 1.09
Identical ends are not required for the equal encapsidation of plus- and minus-strand parvovirus LuIII DNA. J Virol (1989) 1.05
Origin of adeno-associated virus DNA replication is a target of carcinogen-inducible DNA amplification. J Virol (1991) 1.03
Influence of adeno-associated virus on adherence and growth properties of normal cells. J Virol (1992) 1.02
Cell lines inducibly expressing the adeno-associated virus (AAV) rep gene: requirements for productive replication of rep-negative AAV mutants. J Virol (1994) 0.99
A chimeric protein containing the N terminus of the adeno-associated virus Rep protein recognizes its target site in an in vivo assay. J Virol (2000) 0.99
Factors affecting the terminal resolution site endonuclease, helicase, and ATPase activities of adeno-associated virus type 2 Rep proteins. J Virol (1999) 0.95
Expression of human herpesvirus 6B rep within infected cells and binding of its gene product to the TATA-binding protein in vitro and in vivo. J Virol (2000) 0.91
Adeno-associated virus type 2 rep protein inhibits human papillomavirus type 16 E2 recruitment of the transcriptional coactivator p300. J Virol (2000) 0.90
Analysis of the effects of charge cluster mutations in adeno-associated virus Rep68 protein in vitro. J Virol (1999) 0.90
Adeno-associated virus sensitizes HeLa cell tumors to gamma rays. J Virol (1992) 0.89
Restriction of porcine parvovirus replication in nonpermissive cells. J Virol (1992) 0.89
Selective killing of transformed rat cells by minute virus of mice does not require infectious virus production. J Virol (1990) 0.88
A genetic screen identifies a cellular regulator of adeno-associated virus. Proc Natl Acad Sci U S A (2001) 0.85
Adeno-associated virus rep protein-mediated inhibition of transcription of the adenovirus major late promoter in vitro. J Virol (2006) 0.80
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet (1982) 54.79
Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell (1977) 18.95
ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES. Science (1965) 9.77
Nucleotide sequence and organization of the adeno-associated virus 2 genome. J Virol (1983) 7.52
Definition of a novel promoter for the major adenovirus-associated virus mRNA. Cell (1980) 7.42
Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc Natl Acad Sci U S A (1966) 7.35
Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants. J Virol (1984) 5.89
Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci U S A (1982) 5.73
Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate. Nucleic Acids Res (1983) 5.61
Adenovirus E1a proteins repress transcription from the SV40 early promoter. Cell (1985) 5.59
Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. Cell (1983) 5.27
Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function. J Virol (1984) 4.98
Concatemers of alternating plus and minus strands are intermediates in adenovirus-associated virus DNA synthesis. Proc Natl Acad Sci U S A (1976) 4.62
Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J Virol (1985) 4.35
Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci U S A (1984) 3.92
Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J Virol (1981) 3.72
Positive and negative autoregulation of the adeno-associated virus type 2 genome. J Virol (1986) 3.67
Negative and positive regulation in trans of gene expression from adeno-associated virus vectors in mammalian cells by a viral rep gene product. Mol Cell Biol (1986) 3.34
Identification of the trans-acting Rep proteins of adeno-associated virus by antibodies to a synthetic oligopeptide. J Virol (1986) 3.09
Spliced adenovirus-associated virus RNA. Proc Natl Acad Sci U S A (1979) 2.99
Mapping of the 5' termini of two adeno-associated virus 2 RNAs in the left half of the genome. J Virol (1982) 2.75
Replication of adeno-associated virus DNA. Complementation of naturally occurring rep- mutants by a wild-type genome or an ori- mutant and correction of terminal palindrome deletions. J Mol Biol (1984) 2.51
Adeno-associated virus autointerference. Virology (1979) 2.43
Transcripts of the adeno-associated virus genome: mapping of the major RNAs. J Virol (1980) 2.42
A human parvovirus, adeno-associated virus, as a eucaryotic vector: transient expression and encapsidation of the procaryotic gene for chloramphenicol acetyltransferase. Mol Cell Biol (1984) 2.36
A cascade of adenovirus early functions is required for expression of adeno-associated virus. Cell (1981) 2.33
Vaccinia virus, herpes simplex virus, and carcinogens induce DNA amplification in a human cell line and support replication of a helpervirus dependent parvovirus. Virology (1986) 2.26
A stable bovine papillomavirus hybrid plasmid that expresses a dominant selective trait. Mol Cell Biol (1983) 2.21
Eukaryotic translational control: adeno-associated virus protein synthesis is affected by a mutation in the adenovirus DNA-binding protein. Proc Natl Acad Sci U S A (1981) 2.08
Locations of adenovirus genes required for the replication of adenovirus-associated virus. Proc Natl Acad Sci U S A (1981) 1.90
Adeno-associated virus proteins: origin of the capsid components. J Virol (1984) 1.84
Effect of deletions in adenovirus early region 1 genes upon replication of adeno-associated virus. J Virol (1982) 1.76
Inhibition of adenovirus-transformed cell oncogenicity by adeno-associated virus. Virology (1981) 1.65
Vector expression of adenovirus type 5 E1a proteins: evidence for E1a autoregulation. Mol Cell Biol (1985) 1.49
Requirement for either early region 1a or early region 1b adenovirus gene products in the helper effect for adeno-associated virus. J Virol (1984) 1.45
Influence of adeno-associated satellite virus on adenovirus-induced tumours in hamsters. Nat New Biol (1973) 1.28
Effect of adeno-associated virus on cancer expression by herpesvirus-transformed hamster cells. J Natl Cancer Inst (1975) 1.12
Efficient DNA-mediated transfer of selectable genes and unselected sequences into differentiated and undifferentiated mouse melanoma clones. Somat Cell Mol Genet (1984) 1.10
Studies on the relationship between adeno-associated virus type 1 (AAV-1) and adenoviruses. II. Inhibition of adenovirus plaques by AAV; its nature and specificity. Virology (1967) 1.06
Nucleotide sequence and organization of the adeno-associated virus 2 genome. J Virol (1983) 7.52
Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A (1990) 7.06
Heat-stable enterotoxin of Escherichia coli: in vitro effects on guanylate cyclase activity, cyclic GMP concentration, and ion transport in small intestine. Proc Natl Acad Sci U S A (1978) 6.01
Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants. J Virol (1984) 5.89
Evidence for a single-stranded adenovirus-associated virus genome: formation of a DNA density hybrid on release of viral DNA. Proc Natl Acad Sci U S A (1969) 5.78
Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci U S A (1982) 5.73
Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. Cell (1983) 5.27
Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J Virol (1980) 5.09
Evidence for a single-stranded adenovirus-associated virus genome: isolation and separation of complementary single strands. J Virol (1970) 4.73
Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J (1992) 4.36
Characteristics and taxonomy of Parvoviridae. Intervirology (1985) 3.70
Positive and negative autoregulation of the adeno-associated virus type 2 genome. J Virol (1986) 3.67
Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA. J Virol (1980) 3.52
Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics (1991) 3.47
Characterization and localization of the naturally occurring cross-links in vaccinia virus DNA. J Mol Biol (1974) 3.20
Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development (1995) 3.19
Origin and termination of adeno-associated virus DNA replication. Virology (1977) 3.14
Detection of adeno-associated virus (AAV)-specific nucleotide sequences in DNA isolated from latently infected Detroit 6 cells. Virology (1975) 2.77
Mapping of the 5' termini of two adeno-associated virus 2 RNAs in the left half of the genome. J Virol (1982) 2.75
The recombination signals for adeno-associated virus site-specific integration. Proc Natl Acad Sci U S A (1996) 2.74
Adeno-associated viruses: an update. Adv Virus Res (1987) 2.71
Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein. J Virol (1989) 2.53
Organization of adeno-associated virus DNA in latently infected Detroit 6 cells. Virology (1989) 2.43
Transformation of the gene for hypoxanthine phosphoribosyltransferase. Somatic Cell Genet (1979) 2.42
Natural occurrence of cross-linked vaccinia virus deoxyribonucleic acid. J Virol (1970) 2.41
A chimeric mammalian transactivator based on the lac repressor that is regulated by temperature and isopropyl beta-D-thiogalactopyranoside. Proc Natl Acad Sci U S A (1991) 2.35
Adeno-associated viruses. Adv Virus Res (1979) 2.35
Arrangement of nucleotide sequences in adeno-associated virus DNA. J Mol Biol (1973) 2.30
Letter: Visualization of the inverted terminal repetition in adeno-associated virus DNA. J Mol Biol (1974) 2.25
Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc Natl Acad Sci U S A (1994) 2.25
Separation of two types of adeno-associated virus particles containing complementary polynucleotide chains. J Virol (1972) 2.15
Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A (1996) 2.12
Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome. J Virol (1995) 2.02
Conformation takes precedence over sequence in adeno-associated virus DNA replication. Mol Cell Biol (1984) 1.96
Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice. Pharm Res (1997) 1.91
Heterogeneity of expression of E- and P-selectins in vivo. Circ Res (1996) 1.91
Sequence and symmetry requirements within the internal palindromic sequences of the adeno-associated virus terminal repeat. Virology (1988) 1.88
SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. Proc Natl Acad Sci U S A (1998) 1.78
Structure and nucleotide sequence of the terminal regions of adeno-associated virus DNA. Virology (1977) 1.75
Adeno-associated virus DNA replication: nonunit-length molecules. Virology (1979) 1.74
Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors. Gene Ther (2001) 1.71
Inhibition of adenovirus-transformed cell oncogenicity by adeno-associated virus. Virology (1981) 1.65
Adeno-associated virus DNA replication. Cold Spring Harb Symp Quant Biol (1979) 1.65
The remaining stocks of smallpox virus should be destroyed. Science (1993) 1.62
In vitro rescue of an integrated hybrid adeno-associated virus/simian virus 40 genome. J Mol Biol (1991) 1.61
Study of the fine structure of adeno-associated virus DNA with bacterial restriction endonucleases. J Virol (1975) 1.60
In vitro replication of adeno-associated virus DNA. Proc Natl Acad Sci U S A (1992) 1.60
Adeno-associated virus DNA replication in vitro: activation by a maltose binding protein/Rep 68 fusion protein. J Virol (1994) 1.56
Effect of DNA-dependent protein kinase on the molecular fate of the rAAV2 genome in skeletal muscle. Proc Natl Acad Sci U S A (2001) 1.45
The adeno-associated virus rep gene inhibits replication of an adeno-associated virus/simian virus 40 hybrid genome in cos-7 cells. J Virol (1988) 1.42
Genome localization of adeno-associated virus RNA. J Virol (1976) 1.36
Parvovirus gene regulation. J Gen Virol (1987) 1.35
Expression of the herpes simplex virus 1 alpha transinducing factor (VP16) does not induce reactivation of latent virus or prevent the establishment of latency in mice. J Virol (1991) 1.31
Adenovirus early region 1b gene function required for rescue of latent adeno-associated virus. Virology (1980) 1.28
Isolation of nontoxinogenic mutants of Vibrio cholerae in a colorimetric assay for cholera toxin using the S49 mouse lymphosarcoma cell line. J Infect Dis (1978) 1.26
Regulation of adeno-associated virus DNA replication. Biochim Biophys Acta (1988) 1.26
Interactions between the termini of adeno-associated virus DNA. J Mol Biol (1989) 1.25
The supX-leu-500 mutations and expression of the leucine operon. Mol Gen Genet (1973) 1.24
SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development. Immunity (1998) 1.22
In vitro replication of adeno-associated virus DNA: enhancement by extracts from adenovirus-infected HeLa cells. J Virol (1996) 1.18
Role of the adenovirus DNA-binding protein in in vitro adeno-associated virus DNA replication. J Virol (1998) 1.15
Evidence for two nucleotide sequence orientations within the terminal repetition of adeno-associated virus DNA. J Virol (1977) 1.14
Recombination between simian virus 40 and adeno-associated virus: virion coinfection compared to DNA cotransfection. Virology (1984) 1.14
Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression. J Immunol (1999) 1.13
Structure of simian virus 40-adeno-associated virus recombinant genomes. J Virol (1985) 1.13
Inverted terminal repetition in adeno-associated virus DNA: independence of the orientation at either end of the genome. J Virol (1981) 1.12
IL-1 receptor accessory protein is an essential component of the IL-1 receptor. J Immunol (1998) 1.12
Separation of a new deoxyribonucleic acid polymerase from vaccinia-infected HeLa cells. J Virol (1969) 1.10
Efficient DNA-mediated transfer of selectable genes and unselected sequences into differentiated and undifferentiated mouse melanoma clones. Somat Cell Mol Genet (1984) 1.10
DNA sequence motifs which direct adeno-associated virus site-specific integration in a model system. J Virol (2000) 1.07
Direct demonstration of genetic alterations at the dihydrofolate reductase locus after gamma irradiation. Mol Cell Biol (1982) 1.06
Intermediates of adeno-associated virus DNA replication in vitro. J Virol (1994) 1.04
Cytokine induction of an alternatively spliced murine vascular cell adhesion molecule (VCAM) mRNA encoding a glycosylphosphatidylinositol-anchored VCAM protein. Proc Natl Acad Sci U S A (1993) 1.03
Minimum origin requirements for linear duplex AAV DNA replication in vitro. Virology (1995) 1.02
Adeno-associated virus (AAV) site-specific integration: formation of AAV-AAVS1 junctions in an in vitro system. Proc Natl Acad Sci U S A (1999) 1.02
Site-specific integration by adeno-associated virus: a basis for a potential gene therapy vector. Gene Ther (1997) 0.94
Adeno-associated virus type 2: a latent life cycle. Prog Nucleic Acid Res Mol Biol (1994) 0.94
Characterization of a bipartite recombinant adeno-associated viral vector for site-specific integration. Hum Gene Ther (2007) 0.92
Molecular biology of the adeno-associated viruses. Curr Top Microbiol Immunol (1974) 0.92
Regulated high-level human beta-globin gene expression in erythroid cells following recombinant adeno-associated virus-mediated gene transfer. Gene Ther (1995) 0.92
Cloning, expression, and partial purification of Rep78: an adeno-associated virus replication protein. Virology (1994) 0.92
Molecular biology of adeno-associated viruses. Contrib Microbiol (2000) 0.90
CD54/ICAM-1 is a costimulator of NK cell-mediated cytotoxicity. Cell Immunol (1994) 0.89
Site-specific integration of adeno-associated virus into an episome with the target locus via a deletion-substitution mechanism. J Virol (1998) 0.89
CD45-cross-linking stimulates IFN-gamma production in NK cells. J Immunol (1995) 0.89
DNA-mediated transfer of human melanoma cell surface glycoprotein gp130: identification of transfectants by erythrocyte rosetting. Mol Cell Biol (1985) 0.88
Stimulation of IFN-gamma, TNF-alpha, and TNF-beta secretion in IL-2-activated T cells: costimulatory roles for LFA-1, LFA-2, CD44, and CD45 molecules. Cell Immunol (1992) 0.86
Increased PRPP synthetase activity in cultured rat hepatoma cells containing mutations in the hypoxanthine-guanine phosphoribosyltransferase gene. J Cell Physiol (1976) 0.86
Oxidant inhibition of alphaLbeta2 integrin adhesion: evidence for coordinate effects on conformation and cytoskeleton linkage. J Leukoc Biol (1998) 0.84
Cre-mediated generation of a VCAM-1 null allele in transgenic mice. Transgenic Res (1997) 0.84
Unique events in parvovirus replication. Microbiol Sci (1984) 0.84
Recovery of herpes simplex type 1 from the celiac ganglion after renal transplantation. South Med J (1984) 0.83
Simplified production of a recombinant human angiostatin derivative that suppresses intracerebral glial tumor growth. Clin Cancer Res (1999) 0.81
Polyoma-like particle: characterization of the DNA encapsidated in vitro by polyoma empty capsids. J Biol Chem (1982) 0.81
Reproduction in mice lacking a functional type 1 IL-1 receptor. Endocrinology (1996) 0.81
Mechanism of catecholamine-mediated destabilization of messenger RNA encoding Thy-1 protein in T-lineage cells. J Immunol (1998) 0.80